Amneal Pharmaceuticals (AMRX) Exchange Rate Effect (2017 - 2026)
Amneal Pharmaceuticals' (AMRX) quarterly Exchange Rate Effect came in at -$1.0 million in Q1 2026, down 117.66% year-on-year from $5.8 million in Q1 2025, and down 389.47% quarter-over-quarter from -$209000.0 in Q4 2025.
Amneal Pharmaceuticals (AMRX) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Exchange Rate Effect history runs 10 years deep, the most recent figure standing at -$1.0 million for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 117.66% year-over-year to -$1.0 million in Q1 2026; TTM through Mar 2026 was -$2.2 million, a 71.24% decrease from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 68.17% from the prior year.
- Exchange Rate Effect retreated to -$1.0 million in Q1 2026 per AMRX's latest filing, from -$209000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $767000.0 in Q1 2023 and bottomed at -$3.7 million in Q4 2022.
- The 5-year median for Exchange Rate Effect is -$307000.0 (2025), against an average of -$548235.3.
- Across the five-year window, Exchange Rate Effect jumped 148.79% in 2023 and slumped 10014.29% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$3.7 million in 2022, then jumped by 105.38% to $201000.0 in 2023, then tumbled by 468.16% to -$740000.0 in 2024, then soared by 71.76% to -$209000.0 in 2025, then tumbled by 389.47% to -$1.0 million in 2026.
- Per Business Quant, the three latest AMRX Exchange Rate Effect figures stand at -$1.0 million (Q1 2026), -$209000.0 (Q4 2025), and -$694000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.67 Bn | 320.11 Mn | -1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.02 Mn |
| Mar 31, 2026 | -1.02 Mn |
| Dec 31, 2025 | -209,000.00 |
| Dec 31, 2025 | -209,000.00 |
| Sep 30, 2025 | -694,000.00 |
| Sep 30, 2025 | -694,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Mar 31, 2025 | -470,000.00 |
| Mar 31, 2025 | -470,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | -165,000.00 |
| Mar 31, 2024 | -165,000.00 |
| Dec 31, 2023 | 201,000.00 |
| Dec 31, 2023 | 201,000.00 |